Related Experiment Video
Updated: Nov 10, 2025

Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular
Alessandro Maloberti1, Irene Bossi2, Elena Tassistro3
1Cardiology IV, "A.De Gasperis" Department, Ospedale Niguarda Ca' Granda, Milan, Italy; School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy.
Insights
High uric acid (UA) levels did not correlate with coronary artery disease or diastolic dysfunction in patients with chronic coronary syndromes (CCS). Further research may explore UA
Area of Science:
- Cardiology
- Clinical Research
- Biochemistry
Background:
- Uric acid (UA) is linked to cardiovascular (CV) events in chronic coronary syndromes (CCS).
- Hypotheses suggest UA may worsen coronary atherosclerosis or cause diastolic dysfunction.
- This study investigated these potential roles of UA.
Purpose of the Study:
- To determine if uric acid levels are associated with the severity of coronary artery disease in CCS patients.
- To investigate the relationship between uric acid levels and left ventricular (LV) diastolic dysfunction in CCS patients.
Main Methods:
- 231 CCS patients from Niguarda Hospital (Jan 2017-June 2018) were analyzed.
- Coronary angiography assessed atherosclerotic burden (vessel involvement, Gensini/Syntax scores).
- Echocardiography evaluated systolic and diastolic function.
Main Results:
- Uric acid levels showed no significant association with coronary angiography findings (vessel number/type, Gensini/Syntax scores).
- UA levels were not significantly linked to echocardiographic parameters of systolic or diastolic function.
- No correlation was found between UA and disease severity or LV diastolic dysfunction in CCS.
Conclusions:
- Uric acid does not appear to play a role in established coronary artery disease or LV diastolic dysfunction in CCS patients.
- UA might influence cardiovascular health in earlier disease stages.
- In advanced CCS, other factors may overshadow the effects of uric acid.
Background And Aims:
Uric Acid (UA) has been related to the development of Cardio-Vascular (CV) events in patients affected by Chronic Coronary Syndromes (CCS). Among various hypothesis, two arise: UA may negatively act on coronary artery determining a higher degree of atherosclerotic disease, and/or on heart determining a higher prevalence of diastolic dysfunction. Both the above hypothesized effects are object of our investigation.
Methods And Results:
231 patients who were admitted to the cardiological department of the Niguarda Hospital (Milan, Italy) for CCS from January 2017 to June 2018 were enrolled. Coronary atherosclerotic burden was evaluated from coronary angiography as the number and type of involved vessels, as well as with both Gensini and Syntax scores. All subjects underwent a complete echocardiogram. At unadjusted and adjusted/multivariable analysis, UA levels were not significantly associated with variables analysed from the coronary angiography (number and type of vessels involved, neither the Gensini and Syntax scores) as well as with echocardiographic parameters regarding systolic and diastolic function.
Conclusions:
In conclusion, the main finding of our work is the absence of a role for UA in determining coronary arteries disease as well as LV diastolic dysfunction in CCS subjects. Taking together the results of previous studies with ours, we hypothesize that UA could act on heart (both on coronary arteries and on LV function) in an early phase of the disease, whereas while in the advanced stages other factors (previous myocardial infarction, previous myocardial revascularization and so on) may overshadow its effects.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures

